Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Addus HomeCare (ADUS)

Addus HomeCare Q2 Revenue Rises 8.0% to $377.4 Million; Diluted EPS $1.49

Positive Impact 3 of 5 earnings Written later

Addus HomeCare reported second-quarter 2026 net service revenues of $377.4 million, up 8.0% from $349.4 million a year earlier. Net income rose to $27.6 million, or $1.49 per diluted share, from $1.20 per diluted share in the prior-year quarter. Because revenue, profit and per-share earnings all improved, the results point in a favorable direction for shareholders, though the filing gives no forward guidance.

Key points

  • Net service revenues were $377.4 million, up 8.0% from $349.4 million in Q2 2025
  • Net income was $27.6 million, or $1.49 per diluted share, versus $1.20 a year earlier
  • Adjusted EBITDA rose 11.9% to $49.2 million; cash flow from operations was $40.0 million
  • Results were released August 3, 2026; the conference call is set for August 4, 2026 at 9:00 a.m. Eastern Time

The filing

CompanyAddus HomeCare (ADUS)
Form8-K, current report
Filed with the SECAug 3, 2026, 4:25 PM ET
Accession number0001437749-26-025448

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.